Shareholders meeting

4th September, 2026 BSE Limited National Stock Exchange of India Ltd Listing Department, Listing Department, Mumbai 400001, India Mumbai 400051, India Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub:- Notice of the 43rd Annual General Meeting (AGM) for the FY 2025- 26 as required under Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We wish to inform you that the 43rd Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, September 30, 2026, at 11:00 A.M. (IST) through Video Conferencing VC/ Other Audio-Visual Means, pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are herewith enclosing the notice of 43rd Annual General Meeting (AGM) for the financial year 2025- 26. The date and time of remote e-voting facility are as under: Cut-off date for e-voting Friday, 25th September, 2026 E-voting start date and time Sunday, 27th September 2026 at 9.00 A.M. (IST) E-voting start date and time Tuesday, 29th September 2026 at 5.00 P.M. (IST) This is for your information and records Thanking you Yours faithfully For NATCO Pharma Limited Ch Venkat Ramesh Company Secretary & Compliance Officer Encl: as above Notice 385 Notice to Members Notice is hereby given that the 43rd Annual General Meeting of things as it may deem fit, necessary and delegate to any the members of the Company will be held on Wednesday, the Director(s) or Company Secretary or any other Officer(s) of 30th day of September, 2026 at 11.00 a.m. IST through Video the Company for obtaining permissions and approvals, if Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) to any, in this connection.” transact the following business: 5. To approve raising of funds in one or more tranches, by issuance of securities by way of preferential ORDINARY BUSINESS: issue, rights issue, private placement (including 1. Adoption of audited Annual Financial Statements qualified institutions placement(s)) and/or any for the Financial Year 2025-26 combination thereof or any other method as may be permitted under applicable law for an amount To receive, consider and adopt the Audited Financial not exceeding H 2,000 crores Statements, both on Standalone and Consolidated basis of the Company for the Financial Year ended March 31, To consider, and if thought fit, to pass the following 2026, together with the reports of Board of Directors, and resolution as a Special Resolution: the Auditors and other reports thereon. “RESOLVED THAT pursuant to Sections 23, 41, 42, 62, 2. To confirm three interim dividends aggregating to 71, and other applicable provisions of the Companies J5.00 per share paid on equity shares during the Act, 2013 and the applicable rules made thereunder Financial Year 2025-26 as dividend for the FY 2025-26. (including the Companies (Prospectus and Allotment of Securities) Rules, 2014 and the Companies (Share 3. Re-appointment of Sri P.S.R.K. Prasad (DIN: Capital and Debentures) Rules, 2014), each including 07011140) as a Director liable to retire by rotation any amendment(s), statutory modification(s), or re- To consider and, if thought fit, to pass the following enactment(s) thereof ("Companies Act") and in resolution as an Ordinary Resolution: accordance with the provisions of the memorandum of association and articles of association of the Company, “RESOLVED THAT Sri P.S.R.K. Prasad (DIN: 07011140) the Securities and Exchange Board of India (Issue of who retires by rotation and being eligible offers himself Capital and Disclosure Requirements) Regulations, for re-appointment, be and is hereby re-appointed 2018 ("SEBI ICDR Regulations"), the Securities and as a Director of the Company, who shall be liable for Exchange Board of India (Listing Obligations and retirement by rotation.” Disclosure Requirements) Regulations, 2015, and the Foreign Exchange Management Act, 1999 and the SPECIAL BUSINESS: regulations made thereunder, including the Foreign 4. Ratification of remuneration of Cost Auditors Exchange Management (Non-Debt Instruments) Rules, 2019, Foreign Exchange Management (Debt Instruments) To consider and, if thought fit, with or without modifications, Rules, 2019, as amended, the Consolidated FDI Policy to pass the following resolution as an Ordinary Resolution: issued by the Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry, “RESOLVED THAT pursuant to Section 148 of the Government of India from time to time, the Issue of Companies Act, 2013 (‘Act’) and Rule 6 of the Companies Foreign Currency Convertible Bonds and Ordinary Shares (Cost Records and Audit) Rules, 2014 and all other (Through Depository Receipt Mechanism) Scheme, applicable provisions, if any, of the Act and the rules 1993, the Depository Receipts Scheme, 2014 each as made thereunder, as amended from time to time, the remuneration of H5,00,000/- (Rupees five lakhs only) amended; the listing agreements entered into by the Company with BSE Limited and National Stock Exchange and taxes as applicable plus out of pocket expenses of India Limited (collectively, the (“Stock Exchanges”) proposed to be paid to M/s. S.S. Zanwar & Associates where the equity shares of face value of H 2/- each of (Firm Registration No.100283) Cost Auditors who were re- the Company are listed (such equity shares, the “Equity appointed by the Board of Directors of the Company to Shares”); and any other provisions of applicable law conduct the Cost Audit for the financial year ending March (including all other applicable statutes, clarifications, 31, 2027, be and is hereby ratified. rules, regulations, circulars, notifications, and guidelines RESOLVED FURTHER THAT the Board be and is hereby issued by the Government of India (“GoI”), Ministry of authorized to do all such acts, deeds, matters and Corporate Affairs (“MCA”), the Registrar of Companies, 386 Natco Pharma Limited Annual Report 2025-26 Hyderabad at Telangana (“RoC”), Reserve Bank of India or premium to market price or prices permitted under (“RBI”), Securities and Exchange Board of India (“SEBI”), applicable law), in such manner, and on such terms Stock Exchanges, and such other statutory / regulatory and conditions as may be deemed appropriate by the authorities), and subject to all approvals, permissions, Board in its absolute discretion, including the discretion consents, and / or sanctions as may be necessary or to determine to whom the offer, issue and allotment of required from SEBI, the Stock Exchanges, RBI, MCA, GoI, Securities shall be made to the exclusion of others or any other concerned statutory / regulatory authority, (including allotment to stabilizing agent in terms of green and subject to such terms, conditions, or modifications shoe option, if any, exercised by the Company); making as may be prescribed or imposed while granting such of calls and manner of appropriation of application approvals, permissions, consents, and / or sanctions by money or call money, in respect of different class(es) any of the aforesaid authorities, which will be considered of investors and / or in respect of different Securities; by the board of directors of the Company ("Board", which number of securities to be issued; face value; number of term shall include any committee which the Board may Equity Shares to be issued and allotted on conversion / have constituted or may hereinafter constitute to exercise redemption / extinguishment of debt(s); rights attached to its powers, including the powers conferred by this the warrants; period of conversion; fixing of record date; resolution), approval of the members of the Company be and / or book closure dates subject to the applicable and is hereby accorded to the Board and the Board be and laws considering the prevailing market conditions and is hereby authorised to offer, issue, and allot (including with / or other relevant factors, and wher [Showing first 8,000 characters — download PDF for full document]